Amoako Nicholas, Asante Kwaku Poku, Adjei George, Awandare Gordon A, Bimi Langbong, Owusu-Agyei Seth
Kintampo Health Research Centre, Kintampo, Brong Ahafo Region, Ghana.
Infectious Diseases Research Laboratory, Department of Biochemistry, Cell and Molecular Biology. University of Ghana, Legon, Ghana.
PLoS One. 2014 Dec 3;9(12):e112868. doi: 10.1371/journal.pone.0112868. eCollection 2014.
Red blood cell (RBC) polymorphisms are common in malaria endemic regions and are known to protect against severe forms of the disease. Therefore, it is important to screen for these polymorphisms in drugs or vaccines efficacy trials. This study was undertaken to evaluate associations between clinical malaria and RBC polymorphisms to assess biological interactions that may be necessary for consideration when designing clinical trials.
In a cross-sectional study of 341 febrile children less than five years of age, associations between clinical malaria and common RBC polymorphisms including the sickle cell gene and G6PD deficiency was evaluated between November 2008 and June 2009 in the middle belt of Ghana, Kintampo. G6PD deficiency was determined by quantitative methods whiles haemoglobin variants were determined by haemoglobin titan gel electrophoresis. Blood smears were stained with Giemsa and parasite densities were determined microscopically.
The prevalence of clinical malarial among the enrolled children was 31.9%. The frequency of G6PD deficiency was 19.0% and that for the haemoglobin variants were 74.7%, 14.7%, 9.1%, 0.9% respectively for HbAA, HbAC, HbAS and HbSS. In Multivariate regression analysis, children with the HbAS genotype had 79% lower risk of malaria infection compared to those with the HbAA genotypes (OR = 0.21, 95% CI: 0.06-0.73, p = 0.01). HbAC genotype was not significantly associated with malaria infection relative to the HbAA genotype (OR = 0.70, 95% CI: 0.35-1.42, p = 0.33). G6PD deficient subgroup had a marginally increased risk of malaria infection compared to the G6PD normal subgroup (OR = 1.76, 95% CI: 0.98-3.16, p = 0.06).
These results confirm previous findings showing a protective effect of sickle cell trait on clinical malaria infection. However, G6PD deficiency was associated with a marginal increase in susceptibility to clinical malaria compared to children without G6PD deficiency.
红细胞(RBC)多态性在疟疾流行地区很常见,已知可预防严重形式的疾病。因此,在药物或疫苗疗效试验中筛查这些多态性很重要。本研究旨在评估临床疟疾与红细胞多态性之间的关联,以评估在设计临床试验时可能需要考虑的生物学相互作用。
在加纳金坦波中部地区进行的一项针对341名5岁以下发热儿童的横断面研究中,于2008年11月至2009年6月评估了临床疟疾与常见红细胞多态性(包括镰状细胞基因和葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症)之间的关联。G6PD缺乏症通过定量方法测定,而血红蛋白变异体通过血红蛋白泰坦凝胶电泳测定。血涂片用吉姆萨染色,通过显微镜确定寄生虫密度。
登记儿童中临床疟疾的患病率为31.9%。G6PD缺乏症的频率为19.0%,血红蛋白变异体的频率分别为HbAA、HbAC、HbAS和HbSS的74.7%、14.7%、9.1%、0.9%。在多变量回归分析中,与HbAA基因型儿童相比,HbAS基因型儿童疟疾感染风险降低79%(比值比(OR)=0.21,95%置信区间(CI):0.06-0.73,p=0.01)。相对于HbAA基因型,HbAC基因型与疟疾感染无显著关联(OR=0.70,95%CI:0.35-1.42,p=0.33)。与G6PD正常亚组相比,G6PD缺乏亚组疟疾感染风险略有增加(OR=1.76,95%CI:0.98-3.16,p=0.06)。
这些结果证实了先前的研究结果,即镰状细胞性状对临床疟疾感染具有保护作用。然而,与无G6PD缺乏症的儿童相比,G6PD缺乏症与临床疟疾易感性略有增加有关。